Author
Listed:
- June Ereño-Orbea
(The Hospital for Sick Children Research Institute)
- Taylor Sicard
(The Hospital for Sick Children Research Institute
University of Toronto)
- Hong Cui
(The Hospital for Sick Children Research Institute)
- Mohammad T. Mazhab-Jafari
(The Hospital for Sick Children Research Institute)
- Samir Benlekbir
(The Hospital for Sick Children Research Institute)
- Alba Guarné
(McMaster University)
- John L. Rubinstein
(The Hospital for Sick Children Research Institute
University of Toronto
University of Toronto)
- Jean-Philippe Julien
(The Hospital for Sick Children Research Institute
University of Toronto
University of Toronto)
Abstract
CD22 maintains a baseline level of B-cell inhibition to keep humoral immunity in check. As a B-cell-restricted antigen, CD22 is targeted in therapies against dysregulated B cells that cause autoimmune diseases and blood cancers. Here we report the crystal structure of human CD22 at 2.1 Å resolution, which reveals that specificity for α2-6 sialic acid ligands is dictated by a pre-formed β-hairpin as a unique mode of recognition across sialic acid-binding immunoglobulin-type lectins. The CD22 ectodomain adopts an extended conformation that facilitates concomitant CD22 nanocluster formation on B cells and binding to trans ligands to avert autoimmunity in mammals. We structurally delineate the CD22 site targeted by the therapeutic antibody epratuzumab at 3.1 Å resolution and determine a critical role for CD22 N-linked glycosylation in antibody engagement. Our studies provide molecular insights into mechanisms governing B-cell inhibition and valuable clues for the design of immune modulators in B-cell dysfunction.
Suggested Citation
June Ereño-Orbea & Taylor Sicard & Hong Cui & Mohammad T. Mazhab-Jafari & Samir Benlekbir & Alba Guarné & John L. Rubinstein & Jean-Philippe Julien, 2017.
"Molecular basis of human CD22 function and therapeutic targeting,"
Nature Communications, Nature, vol. 8(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00836-6
DOI: 10.1038/s41467-017-00836-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00836-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.